- Home
- TCRX vs HMR Comparison
TCRX vs HMR Comparison
Compare TCRX & HMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | HMR |
|---|---|---|
| Founded | 2018 | 1984 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.1M | 57.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TCRX | HMR |
|---|---|---|
| Price | $0.99 | $0.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $8.50 | $6.00 |
| AVG Volume (30 Days) | ★ 468.8K | 40.8K |
| Earning Date | 03-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,423,000.00 | ★ $36,086,264.00 |
| Revenue This Year | $286.83 | $52.26 |
| Revenue Next Year | N/A | $45.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.41 |
| 52 Week Low | $0.88 | $0.76 |
| 52 Week High | $2.57 | $10.04 |
Technical Indicators
Market Signals| Indicator | TCRX | HMR |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 44.83 |
| Support Level | $0.91 | $0.88 |
| Resistance Level | $1.04 | $1.03 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 15.43 | 11.66 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About HMR Heidmar Maritime Holdings Corp.
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.